PRMT5 and hepatocellular carcinoma: Higher circulating levels of EV lncRNA‐ATB in HCC were linked to decreased OS and progression‐free survival (PFS),325 while uroepithelial carcinoma patients may be at risk of metastasis if they have increased levels of circRNA PRMT5 in the serum and urine.326